Actor Mel Gibson, in a discussion on the Joe Rogan Experience, mentioned that three of his friends with stage four cancer reportedly recovered after using Ivermectin and Fenbendazole. These claims have sparked conversations about alternative cancer treatments, with some social media users citing anecdotal evidence and studies suggesting these drugs might have anti-cancer properties. However, the effectiveness of these treatments for cancer in humans is not broadly recognized by the medical community, and the discussion has led to debates on the promotion and suppression of such treatments by pharmaceutical companies.
Chief Nerd @TheChiefNerd
GIBSON: "I have three friends. All three of them had stage four cancer. All three of them don't have cancer right now at all."
ROGAN: "What did they take?"
GIBSON: "Ivermectin, Fenbendazole"
Poster Comment:
Fenbendazole is a benzimidazole anthelmintic agent commonly used to treat animal parasitic infections. In humans, other benzimidazoles, such as mebendazole and albendazole, are used as antiparasitic agents. Since fenbendazole is not currently approved by the FDA or EMA, its pharmacokinetics and safety in humans have yet to be well-documented in medical literature. Despite this, insights can be drawn from existing in vitro and in vivo animal studies on its pharmacokinetics. Given the low cost of fenbendazole, its high safety profile, accessibility, and unique anti-proliferative activities, fenbendazole would be the preferred benzimidazole compound to treat cancer. To ensure patient safety in the repurposing use of fenbendazole, it is crucial to perform clinical trials to assess its potential anticancer effects, optimal doses, therapeutic regimen, and tolerance profiles
https://ar.iiarjournals.org/content/44/9/3725